Researchers launch study on Ebola treatments as Congo outbreak worsens

Researchers initiated a study on two potential Ebola treatments, remdesivir and MBP134, in Congo to address the worsening Bundibugyo virus outbreak, which has infected over 1,400 people and caused 438 deaths. The trial, led by the WHO and partners, aims to determine if the drugs improve survival rates and will enroll participants in eastern Congo, with possible expansion to safer regions.